Key result
Rare loss-of-function variants across 15 genes are linked to blood pressure regulation.
Why the study?
Although GWAS have identified over 1000 loci associated with blood pressure, the causal genes responsible for these associations remain largely unknown.
Do predicted loss-of-function variants in specific genes associate with differences in systolic or diastolic blood pressure in humans?
Cohort (n=454,709)
Yes
Do predicted loss-of-function variants in specific genes associate with differences in systolic or diastolic blood pressure in humans?
The identification of 15 blood pressure-regulating genes via loss-of-function variants provides new potential targets for blood pressure-lowering therapies and validates causal genes at known GWAS loci.
Answers are grounded in this paper and cite their sources.
pLoF variants in 15 genes associate with BP; extends GWAS loci with candidate causal genes but remains hypothesis-generating for therapy.
BACKGROUND: Hypertension, clinically defined by elevated blood pressure (BP), is an important cause of mortality and morbidity worldwide. Many risk factors for hypertension are known, including a positive family history, which suggests that genetics contribute to interindividual BP variation. Genome-wide association studies (GWAS) have identified > 1000 loci associated with BP, yet the identity of the genes responsible for these associations remains largely unknown. METHODS: To pinpoint genes that causally affect variation of BP in humans, we analyzed predicted loss-of-function (pLoF) variants in the UK Biobank whole-exome sequencing dataset (n = 454,709 participants, 6% non-European ancestry). We analyzed genetic associations between systolic or diastolic BP (SBP/DBP) and single pLoF variants (additive and recessive genetic models) as well as with the burden of very rare pLoF variants (minor allele frequency [MAF] < 0.01%). RESULTS: Single pLoF variants in 10 genes were associated with BP (ANKDD1B, ENPEP, PNCK, BTN3A2, C1orf145 [OBSCN-AS1], CASP9, DBH, KIAA1161 [MYORG], OR4X1, and TMC3). We also found a burden of rare pLoF variants in 5 additional genes associated with BP (TTN, NOS3, FES, SMAD6, COL21A1). Except for PNCK, which is located on the X-chromosome, these genes map near variants previously associated with BP by GWAS, validating the study of pLoF variants to prioritize causal genes at GWAS loci. CONCLUSIONS: Our study highlights 15 genes that likely modulate BP in humans, including 5 genes that harbour pLoF variants associated with lower BP.
No takes yet. Share an insight, caveat, or question.
Lecluze et al. (2023) conducted a cohort in Hypertension / Blood Pressure Variation (n=454,709). Predicted loss-of-function (pLoF) variants vs. Non-carriers of pLoF variants (reference alleles) was evaluated on Systolic and diastolic blood pressure (SBP/DBP). Predicted loss-of-function (pLoF) variants in 15 genes were associated with blood pressure regulation, including a splice donor variant in DBH that decreased diastolic blood pressure by 1.2 mmHg and a stop gained variant in ENPEP that increased blood pressure by 1.4 mmHg.
Synapse has enriched 10 related papers. Consider them for comparative context: